Stem Cell Therapy Market Size to Surpass USD 921.12 Million with CAGR of 17.3% by 2030, Share, Growth, Demand, Global Trends and Competitive Outlook

MELBOURNE, Feb. 23, 2023 (GLOBE NEWSWIRE) --

Data Bridge Market Research

A qualitative study entitled "

Stem Cell Therapy Market

With over 100+ market data tables and graphs spread across pages, you can easily grasp the full analysis. The Stem Cell Therapy Market Report provides a detailed analysis of market share for key industry players. In the report, you will find the company profiles of the top Stem Cell Therapy brands and market leaders. These include product launches, mergers, joint ventures, and accusations that can have a significant impact on sales, revenue, import, export, and CAGR values. Each segment of the market is analyzed based on its size, growth rate and overall attractiveness. The Stem Cell Therapy market research study reveals key market dynamics.

The Stem Cell Therapy Market Report includes the drivers and limitations for the market as derived from SWOT analysis. It also highlights all recent developments, product launches and joint ventures, mergers and acquisitions made by key brands and players that are driving this market. The market type, size of the organization, availability on-premises, end-users organization types, as well as the availability in North America, South America and Europe are all considered. This report includes the company profiles of the major players and brands in the Stem Cell Therapy Market.

Data Bridge Market Research estimates that the market for stem cell therapy, currently valued at USD 257 millions in 2022, will reach USD 921.12 million by 2030. This is a 17.3% CAGR over the 2023- 2030 forecast period. The market reports by Data Bridge Market Research include insights into market scenarios like market value, growth rate and segmentation, geographic coverage and major players. They also include deep expert analysis, patient epidemiology and pipeline analysis, pricing analysis and regulatory framework.

Get a PDF sample of the Stem Cell Therapy Market at URL

URL

Stem cell therapy

Regenerative medicine therapy is used to heal damaged cells by lowering inflammation, and controlling the immune response. This makes stem cell therapy a viable treatment for many illnesses. There have been studies on stem cell therapies for Multiple Sclerosis, Crohn's disease and Lupus. Stem cell therapies can also be used to treat autoimmune and inflammatory disorders as well as neurological, orthopedic, and trauma disorders.

According to the World Health Organization (WHO), cerebrovascular diseases, neurological disorders and other conditions account for approximately 7.1% of global disease burden. Businesses are conducting fundamental research and preclinical trials to determine the ability of stem cells to heal neurological disorders. Companies are investing significant funds in cellular therapies for cancer. This will support the market's expansion.

Recent Developments

For the treatment of mitochondrial dysfunction-related illnesses, a worldwide license agreement was signed between Minovia Therapeutics, Ltd., and Astellas Pharmaceutical, Inc. in 2021. This partnership will accelerate the development allogeneic mitochondrial therapy initiatives. Both companies will work together to explore potential cell therapy program opportunities using Astellas' genetically engineered, induced pluripotent stem cell technology and Minovia’s MAT platform technology.

In the latest study, we analyze the global market in depth. The current level of competition is taken into consideration, as well as its expected evolution over the next few decades.

Stem Cell Therapy is growing rapidly due to increasing demand, industrialization, consumer awareness and technological improvements. This sector has seen an increase in sales and revenue at an exponential rate. Market size and growth will both increase due to the factors that have driven the market's expansion during the forecast period.

To increase their market share and build client base, leading businesses in Stem Cell Therapy are investing heavily in R&D. The study details the strategy of each company, as well their financial health, revenue and growth rate.

Stem Cell Therapy Market Report: The Fundamental Goal

Every company has goals in the Stem Cell Therapy Market. This report focuses on the most important. It will give you insight into the market's future, competition and potential new products.

Factors that influence the

Stem Cell Therapy Market Size

Growth rate.

In the near future, there will be major changes in the Stem Cell Therapy Market.

Notable Market competitors around the globe

Future Prospects and Product Outlook for Stem Cell Therapy Market

Emerging markets that are promising for the future

The market presents many challenges and threats.

Profiles and sales data for the top Stem Cell Therapy companies around the globe

Firms such as

Mesoblast Ltd (Australia)

Biorestorative Therapies Inc.

Brainstorm Cell Limited. (U.S.)

Cellular Biomedicine Group (U.S.)

ANTEROGEN. C.O., LTD. (South Korea)

JCR Pharmaceuticals Co. Ltd. (Japan)

Takeda Pharmaceutical Company Limited (Japan).

The Complete Research Study is available in PDF Format. URL

URL

Opportunities for key players:

Increasing R&D activities will be a positive sign

The market's growth rate will also be affected by the increased R&D activity and the rising investments of public and private companies. According to the Health Care Price Index, (HCPI), U.S. healthcare spending rose by 3.4% in 2021. This growth shows that federal spending has fallen sharply from the previous year, which was USD 287,000 million in 2020 and USD 170,000 million 2021.

Stem cell therapy has seen a rise in demand due to the prompt treatment of chronic diseases. These positive aspects have led to a higher demand for drugs. Both major and minor market players employ various methods to meet this demand.

Market players can take a strategic initiative to increase the potential for growth.

Companies at the top are working hard to create targeted strategies. These include product launches, approvals and expansions.

For example,

ViaCyte, Inc. and SQZ Biotechnologies teamed up in May 2022 to create and market the microfluidic intracellular transport technology. Both market participants will have the opportunity to share new cell engineering research in hematopoietic and stem cells through this agreement.

Research on Stem Cell Therapy Industry Research - Key Market Segments

Type of product

Mesenchymal cells are derived from bone marrow

Placental Stem Cells or Umbilical Stem Cells

Adipose Tissue Derived Mesenchymal Stem Cells

Type

Allogenic Stem Cell Therapy

Stem Cell Therapy for Autologous Patients

Application

Musculoskeletal Disorders

Acute Graft-Versus Host Disease (AGVHD).

Gastrointestinal Diseases

End User

Distribution Channel

These are the key growth drivers:

Market growth will be driven by the rise in chronic diseases and their incidence.

A majority of people suffer from chronic illnesses. A third of adults in the world have a chronic disease. Many people have suffered from chronic diseases that have negatively impacted their health and quality life. Chronic diseases, including cancer, musculoskeletal, neurological, chronic injuries, cardiovascular, and gastrointestinal disorders, and cancer can lead to hospitalizations, long-term incapacities, a decline of quality of life, or even death.

The mesenchymal stem cell penetrates and integrates into many organs. They can treat lung, spine, autoimmune disorders and liver diseases. It is possible to use stem cells for the treatment of degenerative, immune, and inflammatory tissue diseases.

Market growth will be driven by the growing demand for powerful treatments

Significant R&D investments are a key driver of market expansion. The growth is also driven by the increasing demand for effective treatments to reduce the disease burden over the forecast period. Celavie Biosciences' 5-year exploratory study of Parkinson's disease is ongoing, as of May 2020. The treatment of

Parkinson's disease

The company is currently developing stem cell therapies to regenerate the nervous system. Celavie Biosciences claims that Ok99 stem cell-based exploratory clinical trials for Parkinson's disease proved to be effective.

View a detailed summary of the Research Report at URL

URL

Stem Cell Therapy Market Analysis and Insights:

The countries included in the

Market report on stem cell therapy

U.S., Canada, Mexico, U.K. and Switzerland in North America, Germany and France in Europe, China and Japan in South America, Australia, Thailand and Indonesia in the Philippines, Rest of Asia-Pacific in Asia-Pacific in the Asia-Pacific, Saudi Arabia, U.A.E., South Africa and Egypt in Israel, Rest of Middle East Africa (MEA), Brazil and Argentina in South America

Because of its well-developed healthcare infrastructure, favorable reimbursement policies, and strong stem cell therapy market share, North America is the dominant region. The region's rapid growth can also be attributed to the numerous government initiatives that promote stem cell therapy.

The Asia-Pacific region is projected to experience the fastest growth in the period 2023-2030, due to rising cancer incidence, technological advances, and the rising prevalence of chronic illnesses such as diabetes, cancer, or neurological disorders.

This Market Intelligence Report analyzes some of the most important concerns:

What will happen to the main segments of the international market over the next few decades?

Which are the key players who will be the dominant market players in the future?

Who are the top producers and suppliers in this industry?

What strategies have the most successful companies used to plan for growth and expansion in the future?

What sectors will see the most demand growth in the next few years?

What are the different subsets of buyers that make up this market, you ask?

What regional powerhouse do your foresee becoming the biggest player on the international market?

Is there any consequence to a new coronavirus epidemic?

How can established actors be stopped by newcomers?

Table of Contents

Introduction

Segmentation of the Market

Executive Summary

Premium Insights

Global Stem Cell Therapy Market

Regulations

Market Overview

Market for Stem Cell Therapy in the Global Market by Product Type

Market for Stem Cell Therapy in the Global Market by Type

Global Stem Cell Therapy Market by Application

Market for Stem Cell Therapy in the Global Market by End User

Global Stem Cell Therapy Market by Distribution Channel

Global Stem Cell Therapy Market by Region

Stem Cell Therapy Market in the Global Landscape

SWOT Analysis

Profil of a Company

Questionnaires

Similar Reports

The complete Table of Contents is available at URL

URL

Allogenic Stem Cell Therapy Market

, By Product Type (Adult Stem Cells, Embryonic Stem Cells, Iduced Pluripotent Stem Cells), CellSource (Adipose Tissue and Bone Marrow-Derived Mesenchymal Stem Cells, Cord blood/Embryonic Stem Cells, Other), Applications (Musculoskeletal Disorders, Wounds, Surgery, Cardiovascular Diseases, Surgeries, Gastrointestinal Diseases, Other), End users (Therapeutic Companies, Cell, and Tissues Banks, Tools and Reagent Companies, Service Companies, Cell, and Tissues Banks, Tools and Reagent Companies, Cell, Cell, Cell, Cell, and Tissues Banks, Cell, Cell, Tools and Reagent Companies, Tools and Reagent Companies, Service Companies, Cell, Cell, Cell, Cell, Cell, Cell, Cell, and Tissues Banks, Cell, Cell, and Tissues, and Reagent Companies, Cell,

URL

Cancer Stem Cell Therapy Market

, Type (Cell Separation, Cell Analysis and Molecular Analysis), Cancer Forms (Breast Cancer. Lung Cancer. Colorectal Cancer. Colorectal Cancer. Liver Cancer. Liver Cancer. Liver Cancer. Liver Cancer. Other Cancers. Application (Stem Cell Based Cancer Treatment, Turkey, Russia. Rest of Europe. Japan, China. Australia. Singapore. Malaysia. Thailand. Indonesia. Philippines. Rest of Asia-Pacific. Brazil. Argentina. Rest of South America. South Africa.

URL

North America Stem Cell Therapy market

, By Product Type (Bone Marrow-Derivative Mesenchymal Cells and Placental or Umbilical Stem Cells, and Other), Type (Allogenic Stem Cell Therapy and Self-Protected Stem Cell Therapy), End User (Hospitals and Surgical Centers), Therapeutic Companies, Services Companies and Others), Distribution Channels (Direct Tender, Third Party Distributors).

URL

Europe Stem Cell Therapy Market

, By Product Type (Bone Marrow-Derivative Mesenchymal Cells and Placental or Umbilical Stem Cells, and Other), Type (Allogenic Stem Cell Therapy and Self-Protected Stem Cell Therapy), End User (Hospitals and Surgical Centers), Therapeutic Companies, Services Companies and Other), Distribution Channel (Direct Tender, Third Party Distributors).

URL

Asia-Pacific Stem Cell Therapy Market

, By Product Type (Bone Marrow-Derivative Mesenchymal Cells and Placental or Umbilical Stem Cells, and Other), Type (Allogenic Stem Cell Therapy and Self-Protected Stem Cell Therapy), End User (Hospitals and Surgical Centers), Therapeutic Companies, Services Companies and Others), Distribution Channels (Direct Tender, Third Party Distributors).

URL

Market for Autologous Stem Cells and Non-Stem Cell Based Therapies

, Type (Autologous Stem cells, Autologous non-Stem Cells), Product, Bleed Pressure (BP), Monitoring Devices Pulmonary Pressure Monitoring devices, Intracranial Pressure Monitors Devices, Intracranial Pressure(ICP) Monitoring Equipments), Applications (Neurodegenerative Disorders and Autoimmune Diseases), Cancer and Tumors), End User (Hospitals), Ambulatory Surgical Center), Country, United States, Canada, Mexico. Australia, Singapore.

URL

North America Market for Autologous Stem Cells and Non-Stem Cell Based Therapies

, Type (Autologous stem cells, Autologous non-Stem cells), Product(Blood pressure monitoring devices, Pulmonary pressure monitoring devices, Intracranial pressure monitoring devices), Applications (Eurodegenerative Disorders), Autoimmune Diseases. Cancer and Tumors. Cardiovascular Diseases. End User (Hospitals and Ambulatory Surgical Center). Country (U.S.A., Canada, Mexico).

URL

Cord Stem Cell Banking Market

, By Storage Type (Private, Hybrid, Public Banks), Product type (Cord Blood), Cord Blood Tissue), Service type (Collection, Transportation, Analysis, Storage), Source Type (Umbilical Cord Blood Stem, Bone Marrow Stem, Peripheral Blood Stem), Russia, Rest of Europe (U.S.), Canada, Mexico (Mexico), Australia, Singapore, Malaysian, Thailand, Indonesia and Philippines), Country (U.S.A., Canada, Mexico), UAE, Egypt, UAE, Egypt), UAE, UAE, Egypt (Eg), Egypt, UAE, Egypt), Saudi Arabia, UAE, Egypt (Ma), UAE, Egypt), Israel, Rest of Middle East & Africa, UAE, Egypt), UAE, Egypt, UAE, Egypt, UAE, Egypt, Israel (Reserve of Middle East &Africa, UAE, Egypt, UAE, UAE, Egypt, UAE, UAE, Egypt, UAE, Egypt, UAE, Egypt, UAE, Egypt, UAE, UAE, Egypt, UAE, UAE, UAE, Egypt), Israel, Israel, Rest of Middle East &Aleast &A, Israel, Rest of Middle East, Rest of Middle East, Rest of Middle East, Rest of Middle East, Rest of Middle East & Africa, Rest of Middle East, Rest of Middle East, Rest of Middle East & Africa, Rest of Middle East & Africa, Rest of Middle East & Africa, Rest of Middle East & Africa, Rest of Middle East, Rest of Middle East & Middle East & Middle East & Middle East & Middle East, Egypt, Israel, Rest of Middle East, Egypt, Rest of Middle East & Africa, Israel, Egypt, Rest of Middle East & Africa, Middle East & Africa, Middle East & Africa, Middle East & Africa, Middle East & Africa, Middle East & Africa).

URL

Stem Cell Banking Market

, By Source (Placental Stem Cells(PSCs), Human Embryo–Derived Stem Cellss (hESCs), Bone Marrow–Derived Stem Cellss (BMSCs), Adipose Tumour-Derived Stem Cellss (ADSCs), Other Stem Cell Resources), Product (Adult Stem Cells and Human Embryonic Cells), IPS Cells), Bank Type, Private, Public, Service, Sample Processing, Analysis, Storage, Storage, Clinical, Research), Application

URL

Stem Cell Manufacturing Market

, By Products (Stem Cell Lines and Instruments, Consumables and Kits), End User (Biotechnology and Pharma Companies, Research Institutes and Academic Institutes. Cell Banks and Tissue Banks. Hospital and Surgical Centers and Other), Distribution Channel (Direct Sales and Third Party Distributor).

URL

Market for Induced Pluripotent Stim Cells (iPSCs).

, By Cell Sources (Skin Cells and blood cells), Type (Human IPSCs and Mice IPSCs), Product(Instruments, Consumables and Kits and Services), End User (Biotechnology and Pharmaceutical Companies, Research Laboratories and Diagnostic Laboratories and Others), Distribution Channels (Direct Tender and Reseller Sales), Country (U.S.A.E., Israel and Rest of Middle East and Africa), Brazil, Argentina and Rest of South America), South Africa, Egypt and Saudi Arabian

URL

Human Embryonic Stem Cell Market

, Type (Totipotent Stem Cells and Pluripotent Stim Cells, Unipotent Stom Cells), Application, Regenerative Medicine, Stem Cell Biology Research Tissue Engineering, Toxicology Monitoring), End User (Research. Clinical Trials. Others), Country (U.S.A., Canada. Mexico, Germany. Australia. Singapore. Malaysia. Thailand. Indonesia. Philippines. Rest of Asia-Pacific, Brazil. Argentina. Rest of South America. South Africa. Saudi Arabia. UAE.

URL

Market for Stem Cell- and Progenitor Cell Based Therapeutics

, By Disease Type (Parkinson Disease and Huntington Disease), Applications, Tissue Engineering, Stem Cells. Gene Therapy. Drug Discovery. Nanotechnology), End-Users (Pharmaceutical and Biotechnology Industries. Hospitals. Research Institutes. Biotechnology Companies. Others) Country (U.S.A., Canada. Mexico, U.K. France, Spain. Netherlands. Belgium. Switzerland. Turkey. Russia, Rest of Europe. Japan, China. India. South Korea. Australia. Singapore. Malaysia.

URL

Adipose Tissue Derived Stem Cells (ADSCS) Market

, By Cell Line (Human Adipose Tissue–Derived Stim Cells, Rat Adipose Tissue–Derived ST Cells), Reagents Media, Sera, Kits), Application, Regenerative Medicine, Tissue Engineering and Cell Therapy, Other, End User (Biotechnology companies, Academic and Research Institutes).

URL

Data Bridge Market Research:

Understanding the current trend is the best way to predict what the future will bring.

Data Bridge Market Research

We are a unique and neoteric market research and consulting company with an unparalleled level of resilience. Data Bridge is determined to find the best market opportunities for you and provide efficient information to help your business thrive in the market. Data Bridge is committed to providing the best solutions for complex business problems and facilitating an easy decision-making process. Data Bridge is the result of wisdom and experience, which was created in Pune in 2015.

Data Bridge Market Research employs over 500 analysts in various industries. More than 40% of Fortune 500 companies worldwide have been served by Data Bridge Market Research. We also have more than 5000+ clients around the world. Data Bridge is adept at creating happy clients who rely on our services with confidence and trust our hard work. We are happy with our 99.9% client satisfaction rate.

Get in touch with us

Data Bridge Market ResearchUS - +1 888387 2818UK : +44 20089 1725Hong Kong : +852 8192 77475

Email:-

EMAIL